The Digital Healthcare Innovation Summit (DHIS) unites the investors, entrepreneurs, providers, payers, and industry leaders who are creating the digital tools that create new therapies and deliver more efficient – and effective – care to patients. Attendees will have the opportunity to network with decision makers from across healthcare.
Registration and Networking Breakfast
Digital Health by the Numbers
The numbers tell the tale. Silicon Valley Bank will present its first deep dive in digital health fundraising, investment, and exits.
Presented by Matt Griffiths, Director, Digital Health and Medical Device, SVB Leerink
Live Episode: Healthcare Is Hard, a Podcast for Insiders
A Deep Dive on Value-Based Healthcare Adoption – Where Are We?
The scales are tipping toward value-based healthcare. In this panel, a mix of panelists from providers and other entities will detail their success stories, providing signpost for healthcare executives and entrepreneurs to follow.
Victor Kats, Managing Director, Ascension Ventures
Networking Coffee Break
Digital Healthcare Public Market Overview
Digital health companies recorded one of their strongest showings on the public market. What does that success look like and what can we expect in 2020?
Presentation Dan Gulbrandson, Managing Director, Information-Driven Healthcare, Piper Jaffray & Co.
PE meets VC: Digital Transformation of Healthcare at Scale
How to Achieve Healthcare Innovation For All
Healthcare economist Jonathan Gruber, PhD, the Ford Professor of Economics at MIT and an advisor to creators of the Affordable Care Act, will explore the role innovation is and will continue to play in the reformation of not only the healthcare industry, but the US economy.
Jonathan Gruber Ford Professor of Economics MIT
2019 Digital Healthcare Innovator Award
Presented by: Danielle Lauzon, Partner, Goodwin Procter LLP
Award Recipient: Glen E. Tullman, Founder, Executive Chairman, Livongo
Interviewed by: Lydia Ramsey, Senior Reporter, Business Insider
Lessons Learned from Livongo’s IPO Story
Building a Strong Case for Real World Evidence
Pharma is partnering with game-changing tech companies to create the real world evidence necessary to speed development, hone clinical testing and justify reimbursement. In this panel, representatives from both will discuss how data will redefine the pharma and healthcare industries.
Rachel Sha, Vice President of Digital Business Development & Licensing, Sanofi
WHO Is Going to Pay for THAT???
Patient care may be the primary focus for many, but this question should drive every entrepreneur, investor, and healthcare executive. This panel will present perspectives from all three of those concerns as they unpack these problems – and identify the solutions – for ensuring new technologies don’t stall at the starting gate without a reimbursement strategy.
Jessica A. Zeaske, Partner, Echo Health Ventures
Jodi Hubler, Managing Director, Lemhi Ventures
Vincent Nelson, Vice President, Medical Affairs in the Office of Clinical Affairs, Blue Cross Blue Shield Association
Nick Naclerio, Ph.D., Founding Partner, Illumina Ventures
Networking Refreshment Break
A Deep Dive into Novel Behavioral Health Tech and Service Models
Dan Gebremedhin, MD, MBA, Partner, Flare Capital Partners
Danish Munir, Vice President, Technology, Genoa Telepsychiatry/United Health Group
Sara Greenbaum, Vice President & GM, Beacon Care Services
Srishti Mirchanani Gallagher, Vice President, Growth, Eleanor Health
David Mou, MD, CMO, Valera Health; Staff Psychiatrist, Massachusetts General Hospital